Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site


Click on country-registry for comparison

FlagCountry-registryRegistration periodTotal registred%No. of excluded casesIncluded cases
HVDCODCONo. follow-upOthersTotal%No.%
China - Hong Kong SAR 1996-2001147087.51.826055815.5138994.5
China - Qidong 1992-2000217100.00.510010.521699.5
China - Shangai 1992-199560688.00.210010.260599.8
China - Tianjin 1991-199956895.20.001010.256799.8
India - Barshi 1993-20004097.50.000000.040100.0
India - Bhopal 1991-19958596.52.42801011.87588.2
India - Chennai 1990-199950499.00.84350397.746592.3
India - Karunagappally 1991-199730100.00.000000.030100.0
India - Mumbai 1992-1994127699.70.3492151.2126198.8
Singapore 1993-1997408100.00.73150184.439095.6
Republic of Korea - Busan 1996-200149697.22.81420163.248096.8
Republic of Korea - Incheon 1997-200125198.00.000110.425099.6
Republic of Korea - Seoul 1993-1997133696.62.8387901178.8121991.2
Thailand - Chiang Mai 1993-1997135100.00.00130139.612290.4
Thailand - Lampang 1990-2000137100.00.000000.0137100.0
Thailand - Songkhla 1990-1999191100.00.00180189.417390.6
Turkey - Izmir 1995-1997149100.00.001010.714899.3



Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period